Cannalean Biotech (Agriculture, Business Opportunities, Medical and Healthcare IT) - NEW
CBD-based Solutions for Treating Dyslipidemia CannaLean Biotechs is committed to the research and development of a proprietary formulation of cannabidiol (CBD) and chitosan that can potentially benefit millions of patients with dyslipidemia. CannaLean uses a synthetic form of CBD, a non-psychotropic component of cannabis, with chitosan, a biocompatible, non-toxic, and non-immunogenic compound that enhances the […]